Doximity Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga05-13

Doximity, Inc. (NYSE:DOCS) will release earnings for its fourth quarter after the closing bell on Wednesday, May 13.

Analysts expect the San Francisco, California-based company to report quarterly earnings of 28 cents per share, down from 38 cents per share in the year-ago period. The consensus estimate for Doximity's quarterly revenue is $143.91 million (it reported $138.29 million last year), according to Benzinga Pro.

On April 17, Doximity announced resignation of Anna Bryson as chief financial officer.

Doximity shares rose 0.7% to close at $26.45 on Tuesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • B of A Securities analyst Allen Lutz maintained a Buy rating and cut the price target from $56 to $47 on April 16, 2026. This analyst has an accuracy rate of 63%.
  • Keybanc analyst Brandon Nispel maintained an Overweight rating and slashed the price target from $38 to $30 on April 13, 2026. This analyst has an accuracy rate of 56%.
  • Evercore ISI Group analyst Elizabeth Anderson downgraded the stock from Outperform to In-Line and cut the price target from $30 to $25 on April 8, 2026. This analyst has an accuracy rate of 52%.
  • JP Morgan analyst Alexeia Gogolev maintained a Neutral rating and cut the price target from $40 to $33 on Feb. 20, 2026. This analyst has an accuracy rate of 60%.
  • Barclays analyst Glen Santangelo maintained an Overweight rating and slashed the price target from $63 to $38 on Feb. 11, 2026. This analyst has an accuracy rate of 50%.

Considering buying DOCS stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment